Michael Basso
Publications by Year
Research Areas
Cholesterol and Lipid Metabolism, Hormonal Regulation and Hypertension, Aldose Reductase and Taurine, Diabetes, Cardiovascular Risks, and Lipoproteins, Heart Failure Treatment and Management
Most-Cited Works
- → Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction(2020)390 cited
- → Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction(2020)204 cited
- → Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats(1997)155 cited
- → Protein kinase C effects on nerve function, perfusion, Na + ,K + -ATPase activity and glutathione content in diabetic rats(1999)131 cited
- → Protective Effect of the Immunosuppressant Sirolimus Against Aortic Atherosclerosis In Apo E-Deficient Mice(2003)125 cited
- → LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse(2009)106 cited
- → Indazole-Based Liver X Receptor (LXR) Modulators with Maintained Atherosclerotic Lesion Reduction Activity but Diminished Stimulation of Hepatic Triglyceride Synthesis(2008)75 cited
- → Endotrophin, a Collagen VI Formation–Derived Peptide, in Heart Failure(2022)57 cited
- → Clinical and Proteomic Correlates of Plasma ACE2 (Angiotensin-Converting Enzyme 2) in Human Heart Failure(2020)53 cited
- → Discovery of Phenyl Acetic Acid Substituted Quinolines as Novel Liver X Receptor Agonists for the Treatment of Atherosclerosis(2006)50 cited